American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

Session Code: PS331
Title: The Next Generation of Prostate Cancer Screening and Diagnosis
Date and Time of Session: Wednesday, October 25: 4:15 pm - 5:45 pm
Description: Prostate cancer is the most common cancer in the U.S. and the second most common cause of cancer death. There remains a significant amount of controversy, uncertainty, and change in practice with regard to appropriate and evidence-based methods for prostate screening and detection methods. The course will seek to improve one's understanding of evidenced-based and selective use of emerging molecular and imaging techniques in prostate cancer screening and diagnosis, and will provide an update of Prostate Specific Antigen (PSA) screening guidelines for men.
CME Credit Hours: 1.5
Webcast Package Available: Yes
Audio Package Available: Yes
Urology (URO)
Credit to Address ACS Accreditation/Verification Requirements:
Sponsored By:
Advisory Council for Urology
Program Participants:
Michael Shawn Cookson, MD, MMHC, FACS
Jeffrey Wells Nix, MD
Speaker Impact of the USPTF Recommendations on Prostate Cancer Screening
Gerald Louis Andriole, MD FACS
Speaker New Prostate Cancer Biomarkers in the Diagnosis of Prostate Cancer
Daniel Wei Lin, MD
Speaker Use of Genomics in Detection and Diagnosis of Prostate Cancer
Christopher J. Kane, MD
Speaker MRI in the Enhanced Detection of Prostate Cancer
Kelly Stratton, MD
Questions and Answers